LEVOLEUCOVORIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Levoleucovorin, and when can generic versions of Levoleucovorin launch?
Levoleucovorin is a drug marketed by Actavis Llc, Amneal, Hikma, Meitheal, Gland, Hainan Poly Pharm, Novast Labs, Pharmobedient, Praxgen, and Sandoz. and is included in thirteen NDAs.
The generic ingredient in LEVOLEUCOVORIN is levoleucovorin calcium. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the levoleucovorin calcium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Levoleucovorin
A generic version of LEVOLEUCOVORIN was approved as levoleucovorin calcium by SANDOZ on March 9th, 2015.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LEVOLEUCOVORIN?
- What are the global sales for LEVOLEUCOVORIN?
- What is Average Wholesale Price for LEVOLEUCOVORIN?
Summary for LEVOLEUCOVORIN
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 13 |
| Drug Prices: | Drug price information for LEVOLEUCOVORIN |
| DailyMed Link: | LEVOLEUCOVORIN at DailyMed |
Recent Clinical Trials for LEVOLEUCOVORIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Daiichi Sankyo | PHASE1 |
| National Cancer Institute (NCI) | PHASE2 |
| Janssen Research & Development, LLC | PHASE3 |
US Patents and Regulatory Information for LEVOLEUCOVORIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Llc | LEVOLEUCOVORIN CALCIUM | levoleucovorin calcium | POWDER;INTRAVENOUS | 206516-001 | Feb 13, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sandoz | LEVOLEUCOVORIN CALCIUM | levoleucovorin calcium | SOLUTION;INTRAVENOUS | 203563-001 | Mar 9, 2015 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Gland | LEVOLEUCOVORIN CALCIUM | levoleucovorin calcium | SOLUTION;INTRAVENOUS | 210892-001 | Sep 14, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hikma | LEVOLEUCOVORIN CALCIUM | levoleucovorin calcium | POWDER;INTRAVENOUS | 206263-001 | Jun 16, 2016 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
